Akutes Nierenversagen – aktuelle Diagnostik und Therapie

Carsten Willam; Stefan John

doi:10.1055/s-0034-1365086

Innere Medizin up2date, Table of Contents

Kardiologie up2date 2014; 02(01): 35-55
DOI: 10.1055/s-0034-1365086

Nieren und Harnwege

Akutes Nierenversagen – aktuelle Diagnostik und Therapie

Acute kidney injury – current diagnosis and treatment

Carsten Willam

,

Stefan John

Abstract

All articles of this category

Full Text

References

Literatur
1 Hsu RK, McCulloch CE, Dudley RA et al. Temporal changes in incidence of dialysis-requiring AKI. J Am Soc Neph 2013; 24: 37-42
2 Nisula S, Kaukonen KM, Vaara ST et al. Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Inten care med 2013; 39: 420-428
3 Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004; 351: 159-169
4 Owan TE, Hodge DO, Herges RM et al. Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients. J Card Fail 2006; 12: 257-262
5 Maeder MT, Holst DP, Kaye DM. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure. J Card Fail 2008; 14: 824-830
6 Nohria A, Hasselblad V, Stebbins A et al. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 2008; 51: 1268-1274
7 KDIGO. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kid Int 2012; 2
8 Forman DE, Butler J, Wang Y et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004; 43: 61-67
9 Lassnigg A, Schmidlin D, Mouhieddine M et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Neph 2004; 15: 1597-1605
10 Kashani K, Al-Khafaji A, Ardiles T et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013; 17: R25
11 Ho KM, Power BM. Benefits and risks of furosemide in acute kidney injury. Anaesthesia 2010; 65: 283-293
12 Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377
13 Lin SM, Huang CD, Lin HC et al. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock 2006; 26: 551-557
14 Brunkhorst FM, Engel C, Bloos F et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-139
15 Myburgh JA, Finfer S, Bellomo R et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901-1911
16 Grams ME, Estrella MM, Coresh J et al. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol: CJASN 2011; 6: 966-973
17 Costanzo MR, Guglin ME, Saltzberg MT et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 675-683
18 Bart BA, Goldsmith SR, Lee KL et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012; 367: 2296-2304
19 Bourgoin A, Leone M, Delmas A et al. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 2005; 33: 780-786
20 Martin C, Viviand X, Leone M et al. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28: 2758-2765
21 Friedrich JO, Adhikari N, Herridge MS et al. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005; 142: 510-524
22 Gattinoni L, Brazzi L, Pelosi P et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995; 333: 1025-1032
23 Follath F, Cleland JG, Just H et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002; 360: 196-202
24 Niu ZZ, Wu SM, Sun WY et al. Perioperative levosimendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery: a meta-analysis. J Cardiovas Pharm 2013; DOI:
25 Schneider V, Levesque LE, Zhang B et al. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis. Am J Epidemiol 2006; 164: 881-889
26 Merten GJ, Burgess WP, Gray LV et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291: 2328-2334
27 Investigators ACT. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 2011; 124: 1250-1259
28 Kellum JA, Angus DC, Johnson JP et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Inten care med 2002; 28: 29-37
29 Vinsonneau C, Camus C, Combes A et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006; 368: 379-385
30 Investigators RRTS. Bellomo R, Cass A et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361: 1627-1638
31 Network VNARFT. Palevsky PM, Zhang JH et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20